Empresa Ampliphi Biosciences Corp Nyse
Acciones
US03211P3010
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pathogen-specific Bacteriophage Therapeutics
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 11/07/23 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 26/10/20 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Richard Rychlik
AUD | Comptroller/Controller/Auditor | 68 | 05/09/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 64 | 12/02/20 | |
Joseph Patti
BRD | Director/Board Member | 60 | 09/05/19 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 01/04/21 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 12/02/20 |
Robin Kramer
CHM | Chairman | 58 | 08/12/20 |
Todd Peterson
BRD | Director/Board Member | 66 | 10/10/19 |
Deborah Birx
CEO | Chief Executive Officer | 68 | 11/07/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 36 154 617 | 10 746 770 ( 29,72 %) | 0 | 29,72 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+41,79 % | 50,93 mil M | |
-0,56 % | 42,12 mil M | |
+49,62 % | 42,05 mil M | |
-7,20 % | 29,18 mil M | |
+12,59 % | 26,02 mil M | |
-21,51 % | 18,9 mil M | |
+6,92 % | 13,21 mil M | |
+24,91 % | 12,17 mil M | |
+29,60 % | 12,16 mil M |